Eli Lilly's insulin copay cap doesn't replace the need for government regulation A few months after congress failed to pass an insulin copay cap of $35 for all insured patients, and a few weeks after President Joe Biden once again raised the issue in his State of the Union address, the US’s largest insulin maker Ely Lilly announced Wednesday a series of price cuts for insulin and the copay.Read more... https://qz.com/eli-lillys-insulin-copay-cap-doesnt-replace-the-need-fo-1850173742
















